$AMMJ
American Cannabis Company, Inc. Stock $ammj

$ammj Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-Q Financial Statement

#000190359622000846 Filed on November 21, 2022

Income Statement

Concept	2022 Q4	2022 Q3	2021 Q3
Revenue	$11.32M	$2.124M	$753.0K
YoY Change	1458.72%	182.04%	180.21%
Cost Of Revenue	$9.851M	$1.864M	$424.2K
YoY Change	2138.5%	339.49%	169.42%
Gross Profit	$1.470M	$259.2K	$328.7K
YoY Change	413.54%	-21.15%	195.48%
Gross Profit Margin	12.98%	12.2%	43.66%
Selling, General & Admin	$904.8K	$681.3K	$590.1K
YoY Change	23.7%	15.45%	110.05%
% of Gross Profit	61.56%	262.86%	179.52%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$114.2K	$40.84K	$68.83K
YoY Change	543.21%	-40.67%	1633.75%
% of Gross Profit	7.77%	15.76%	20.94%
Operating Expenses	$904.8K	$737.5K	$590.1K
YoY Change	23.7%	24.97%	110.05%
Operating Profit	$565.0K	-$478.3K	-$261.4K
YoY Change	-226.89%	82.97%	54.05%
Interest Expense	-$110.1K	$77.38K	-$28.03K
YoY Change	285.81%	-376.06%	1465.92%
% of Operating Profit	-19.49%
Other Income/Expense, Net	$2.530K	$80.63K	$940.00
YoY Change	-92.22%	8477.34%	-97.45%
Pretax Income	$457.4K	-$397.7K	-$158.3K
YoY Change	-157.87%	151.2%	17.63%
Income Tax	$0.00
% Of Pretax Income	0.0%
Net Earnings	$457.4K	-$397.7K	-$158.3K
YoY Change	-157.87%	151.2%	17.63%
Net Earnings / Revenue	4.04%	-18.73%	-21.02%
Basic Earnings Per Share		$0.00	$0.00
Diluted Earnings Per Share	$0.01	-$4.639K	-$1.977K
COMMON SHARES
Basic Shares Outstanding	85.73M shares	85.73M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2022 Q4	2022 Q3	2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$127.1K	$201.1K	$887.0K
YoY Change	-81.12%	-77.33%	-25.94%
Cash & Equivalents	$117.5K	$191.5K	$884.1K
Short-Term Investments	$9.600K	$9.600K	$2.900K
Other Short-Term Assets	$73.93K	$129.7K	$53.60K
YoY Change	43.97%	141.94%	159.94%
Inventory	$353.0K	$352.5K	$277.3K
Prepaid Expenses
Receivables	$469.1K	$259.9K	$45.16K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$1.023M	$943.2K	$1.263M
YoY Change	0.84%	-25.32%	-5.03%
LONG-TERM ASSETS
Property, Plant & Equipment	$427.7K	$442.9K	$543.3K
YoY Change	13.79%	-18.48%	1737.99%
Goodwill	$1.332M	$1.985M
YoY Change	-32.89%
Intangibles	$1.332M	$686.2K
YoY Change	78.58%
Long-Term Investments
YoY Change
Other Assets	$6.000K	$6.000K	$32.89K
YoY Change	0.0%	-81.76%
Total Long-Term Assets	$3.593M	$3.332M	$3.170M
YoY Change	11.98%	5.13%	10622.56%
TOTAL ASSETS
Total Short-Term Assets	$1.023M	$943.2K	$1.263M
Total Long-Term Assets	$3.593M	$3.332M	$3.170M
Total Assets	$4.616M	$4.275M	$4.433M
YoY Change	9.31%	-3.55%	226.05%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$679.2K	$453.7K	$173.8K
YoY Change	179.86%	161.13%	756.38%
Accrued Expenses	$39.13K	$39.11K	$189.4K
YoY Change	-47.22%	-79.35%	187.48%
Deferred Revenue
YoY Change
Short-Term Debt	$550.0K	$550.0K	$1.100M
YoY Change	-50.0%	-50.0%	900.82%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$2.099M	$2.924M	$1.646M
YoY Change	8.81%	77.72%	328.96%
LONG-TERM LIABILITIES
Long-Term Debt	$150.0K	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$497.4K	$93.75K	$8.270K
YoY Change	184.21%	1033.62%
Total Long-Term Liabilities	$613.0K	$93.75K	$8.270K
YoY Change	250.26%	1033.62%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.099M	$2.924M	$1.646M
Total Long-Term Liabilities	$613.0K	$93.75K	$8.270K
Total Liabilities	$2.747M	$3.018M	$1.654M
YoY Change	30.53%	82.5%	331.12%
SHAREHOLDERS EQUITY
Retained Earnings	-$10.08M	-$10.54M
YoY Change	6.7%
Common Stock	$922.00	$856.00
YoY Change	12.58%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.870M	$1.257M	$2.779M
YoY Change
Total Liabilities & Shareholders Equity	$4.616M	$4.275M	$4.433M
YoY Change	9.31%	-3.55%	226.05%

Cashflow Statement

Concept	2022 Q4	2022 Q3	2021 Q3
OPERATING ACTIVITIES
Net Income	$457.4K	-$397.7K	-$158.3K
YoY Change	-157.87%	151.2%	17.63%
Depreciation, Depletion And Amortization	$114.2K	$40.84K	$68.83K
YoY Change	543.21%	-40.67%	1633.75%
Cash From Operating Activities	-$267.7K	-$577.9K	-$308.8K
YoY Change	-13.13%	87.16%	54.07%
INVESTING ACTIVITIES
Capital Expenditures	-$11.64K	-$104.3K	$34.08K
YoY Change	-67.67%	-406.1%	-10750.0%
Acquisitions
YoY Change
Other Investing Activities			$0.00
YoY Change
Cash From Investing Activities	$11.64K	-$104.3K	$34.08K
YoY Change	-132.33%	-406.1%	-10750.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	182.1K	0.000	26.93K
YoY Change	39.49%	-100.0%	-94.61%
NET CHANGE
Cash From Operating Activities	-267.7K	-577.9K	-308.8K
Cash From Investing Activities	11.64K	-104.3K	34.08K
Cash From Financing Activities	182.1K	0.000	26.93K
Net Change In Cash	-73.97K	-682.3K	-247.8K
YoY Change	-65.37%	175.35%	-182.79%
FREE CASH FLOW
Cash From Operating Activities	-$267.7K	-$577.9K	-$308.8K
Capital Expenditures	-$11.64K	-$104.3K	$34.08K
Free Cash Flow	-$256.1K	-$473.6K	-$342.9K
YoY Change	-5.91%	38.13%	71.35%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Central Index Key EntityCentralIndexKey	0000945617
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022Q3	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q3	AMMJ	Debt Forgiveness DebtForgiveness		usd
	AMMJ	Debt Forgiveness DebtForgiveness		usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2021Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	AMMJ	Stock Issued For Cashless Exercise Value StockIssuedForCashlessExerciseValue		usd
	AMMJ	Stockbased Compensation To Third Party StockbasedCompensationToThirdParty		usd
	AMMJ	Debt Forgiveness1 DebtForgiveness1		usd
	AMMJ	Increase Decrease In Long Term Deposits IncreaseDecreaseInLongTermDeposits		usd
	AMMJ	Increase Decrease In Long Term Deposits IncreaseDecreaseInLongTermDeposits		usd
	AMMJ	Increase Decrease In Litigation Settlement Liability IncreaseDecreaseInLitigationSettlementLiability		usd
	us-gaap	Payments To Acquire Other Property Plant And Equipment PaymentsToAcquireOtherPropertyPlantAndEquipment		usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable		usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable		usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	AMMJ	Stock Based Compensation Third Party StockBasedCompensationThirdParty		usd
	AMMJ	Stock Issued For Receivables StockIssuedForReceivables		usd
	AMMJ	Stock Issued For Acquisition StockIssuedForAcquisition		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	000-26108
	dei	Entity Registrant Name EntityRegistrantName	AMERICAN CANNABIS COMPANY, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	90-1116625
	dei	Entity Address Address Line1 EntityAddressAddressLine1	200 Union Street
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Ste. 200
	dei	Entity Address Address Line3 EntityAddressAddressLine3	Lakewood
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CO
	dei	Entity Address City Or Town EntityAddressCityOrTown	Denver
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	80228
	dei	City Area Code CityAreaCode	303
	dei	Local Phone Number LocalPhoneNumber	974-4770
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	85727938	shares
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	191516	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	670423	usd
CY2022Q3	us-gaap	Accounts Receivable Net AccountsReceivableNet	259926	usd
CY2021Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	11316	usd
CY2022Q3	us-gaap	Deposits Assets Current DepositsAssetsCurrent	9595	usd
CY2021Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	2895	usd
CY2022Q3	us-gaap	Inventory Net InventoryNet	352494	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	278608	usd
CY2022Q3	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	129675	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	51353	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	943205	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	1014595	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	442901	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	375832	usd
CY2022Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	686242	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	745937	usd
CY2022Q3	us-gaap	Goodwill Goodwill	1985113	usd
CY2021Q4	us-gaap	Goodwill Goodwill	1985113	usd
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	211913	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	95722	usd
CY2022Q3	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	6000	usd
CY2021Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	6000	usd
CY2022Q3	us-gaap	Other Assets OtherAssets	2889268	usd
CY2021Q4	us-gaap	Other Assets OtherAssets	2832772	usd
CY2022Q3	us-gaap	Assets Assets	4275374	usd
CY2021Q4	us-gaap	Assets Assets	4223199	usd
CY2022Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	453738	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	242679	usd
CY2022Q3	AMMJ	Advances From Client AdvancesFromClient	1390972	usd
CY2021Q4	AMMJ	Advances From Client AdvancesFromClient	111892	usd
CY2022Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	94085	usd
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	161718	usd
CY2022Q3	AMMJ	Stock Payable StockPayable	117479	usd
CY2021Q4	AMMJ	Stock Payable StockPayable	42207	usd
CY2022Q3	AMMJ	Right Of Use Liabilities All Current RightOfUseLiabilitiesAllCurrent	211913	usd
CY2021Q4	AMMJ	Right Of Use Liabilities All Current RightOfUseLiabilitiesAllCurrent	95722	usd
CY2022Q3	us-gaap	Litigation Reserve Current LitigationReserveCurrent	106250	usd
CY2021Q4	us-gaap	Litigation Reserve Current LitigationReserveCurrent	175000	usd
CY2022Q3	us-gaap	Notes Payable Current NotesPayableCurrent	550000	usd
CY2021Q4	us-gaap	Notes Payable Current NotesPayableCurrent	1100000	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	2924436	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1929218	usd
CY2022Q3	us-gaap	Litigation Reserve Noncurrent LitigationReserveNoncurrent	93750	usd
CY2021Q4	us-gaap	Litigation Reserve Noncurrent LitigationReserveNoncurrent	175000	usd
CY2022Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	93750	usd
CY2021Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	175000	usd
CY2022Q3	us-gaap	Liabilities Liabilities	3018186	usd
CY2021Q4	us-gaap	Liabilities Liabilities	2104218	usd
CY2022Q3	us-gaap	Preferred Stock No Par Value PreferredStockNoParValue	0.01
CY2021Q4	us-gaap	Preferred Stock No Par Value PreferredStockNoParValue	0.01
CY2022Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2022Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	85727938	shares
CY2022Q3	us-gaap	Common Stock Other Shares Outstanding CommonStockOtherSharesOutstanding	85727938	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	70727938	shares
CY2021Q4	us-gaap	Common Stock Other Shares Outstanding CommonStockOtherSharesOutstanding	70727938	shares
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	856	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	819	usd
CY2022Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	11794476	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	11565679	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-10538144	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-9447517	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	1257188	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	2118981	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4275374	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4223199	usd
CY2022Q3	AMMJ	Consulting And Advisory Revenues ConsultingAndAdvisoryRevenues	66824	usd
CY2021Q3	AMMJ	Consulting And Advisory Revenues ConsultingAndAdvisoryRevenues	53277	usd
	AMMJ	Consulting And Advisory Revenues ConsultingAndAdvisoryRevenues	308872	usd
	AMMJ	Consulting And Advisory Revenues ConsultingAndAdvisoryRevenues	254669	usd
CY2022Q3	AMMJ	Equipment Supplies Revenues EquipmentSuppliesRevenues	1866725	usd
CY2021Q3	AMMJ	Equipment Supplies Revenues EquipmentSuppliesRevenues	292709	usd
	AMMJ	Equipment Supplies Revenues EquipmentSuppliesRevenues	6540558	usd
	AMMJ	Equipment Supplies Revenues EquipmentSuppliesRevenues	730198	usd
CY2022Q3	AMMJ	Cannabis Products CannabisProducts	190067	usd
CY2021Q3	AMMJ	Cannabis Products CannabisProducts	406967	usd
	AMMJ	Cannabis Products CannabisProducts	638316	usd
	AMMJ	Cannabis Products CannabisProducts	714043	usd
CY2022Q3	us-gaap	Revenues Revenues	2123616	usd
CY2021Q3	us-gaap	Revenues Revenues	752953	usd
	us-gaap	Revenues Revenues	7487746	usd
	us-gaap	Revenues Revenues	1698910	usd
CY2022Q3	AMMJ	Cost Of Consulting And Advisory CostOfConsultingAndAdvisory	19500	usd
CY2021Q3	AMMJ	Cost Of Consulting And Advisory CostOfConsultingAndAdvisory	9473	usd
	AMMJ	Cost Of Consulting And Advisory CostOfConsultingAndAdvisory	67422	usd
CY2021Q3	us-gaap	Gross Profit GrossProfit	328721	usd
	us-gaap	Gross Profit GrossProfit	1067363	usd
	us-gaap	Gross Profit GrossProfit	769927	usd
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	617270	usd
CY2021Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	539340	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1951008	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1428092	usd
CY2022Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	64017	usd
CY2021Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	42455	usd
	AMMJ	Cost Of Consulting And Advisory CostOfConsultingAndAdvisory	36179	usd
CY2022Q3	AMMJ	Cost Of Equipment Supplies CostOfEquipmentSupplies	1664235	usd
CY2021Q3	AMMJ	Cost Of Equipment Supplies CostOfEquipmentSupplies	182795	usd
	AMMJ	Cost Of Equipment Supplies CostOfEquipmentSupplies	5628432	usd
	AMMJ	Cost Of Equipment Supplies CostOfEquipmentSupplies	513051	usd
CY2022Q3	AMMJ	Cost Of Cannabis Product CostOfCannabisProduct	180701	usd
CY2021Q3	AMMJ	Cost Of Cannabis Product CostOfCannabisProduct	231964	usd
	AMMJ	Cost Of Cannabis Product CostOfCannabisProduct	724529	usd
	AMMJ	Cost Of Cannabis Product CostOfCannabisProduct	379753	usd
CY2022Q3	us-gaap	Cost Of Revenue CostOfRevenue	1864436	usd
CY2021Q3	us-gaap	Cost Of Revenue CostOfRevenue	424232	usd
	us-gaap	Cost Of Revenue CostOfRevenue	6420383	usd
	us-gaap	Cost Of Revenue CostOfRevenue	928983	usd
CY2022Q3	us-gaap	Gross Profit GrossProfit	259180	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	165544	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	150301	usd
CY2022Q3	us-gaap	Share Based Compensation ShareBasedCompensation	56170	usd
CY2021Q3	us-gaap	Share Based Compensation ShareBasedCompensation	8318	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	121479	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	37008	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	737458	usd
CY2021Q3	us-gaap	Operating Expenses OperatingExpenses	590113	usd
	us-gaap	Operating Expenses OperatingExpenses	2238032	usd
	us-gaap	Operating Expenses OperatingExpenses	1615401	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-478277	usd
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-261392	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1170668	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-845474	usd
CY2022Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	77381	usd
CY2021Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-28027	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	32024	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-46837	usd
CY2021Q3	AMMJ	Debt Forgiveness DebtForgiveness	-130186	usd
	AMMJ	Debt Forgiveness DebtForgiveness	-240100	usd
CY2022Q3	us-gaap	Other Income OtherIncome	3247	usd
CY2021Q3	us-gaap	Other Income OtherIncome	938	usd
	us-gaap	Other Income OtherIncome	48016	usd
	AMMJ	Debt Forgiveness1 DebtForgiveness1	-240100	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	248610	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	185151	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	73886	usd
	us-gaap	Other Income OtherIncome	3367	usd
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	80627	usd
CY2021Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	103097	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	80040	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	196630	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-397650	usd
CY2021Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-158295	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1090628	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-648844	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-397650	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-158295	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1090628	usd
	us-gaap	Net Income Loss NetIncomeLoss	-648844	usd
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2022Q3	AMMJ	Basic And Diluted Weighted Average Common Shares Outstanding BasicAndDilutedWeightedAverageCommonSharesOutstanding	85727938	shares
CY2021Q3	AMMJ	Basic And Diluted Weighted Average Common Shares Outstanding BasicAndDilutedWeightedAverageCommonSharesOutstanding	8052395	shares
	AMMJ	Basic And Diluted Weighted Average Common Shares Outstanding BasicAndDilutedWeightedAverageCommonSharesOutstanding	84795246	shares
	AMMJ	Basic And Diluted Weighted Average Common Shares Outstanding BasicAndDilutedWeightedAverageCommonSharesOutstanding	77584074	shares
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	2910180	usd
CY2021Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	26935	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-158295	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	2778820	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	1654838	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-397650	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	1257188	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	1627187	usd
	us-gaap	Stock Issued During Period Value Purchase Of Assets StockIssuedDuringPeriodValuePurchaseOfAssets	690000	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1110477	usd
	us-gaap	Net Income Loss NetIncomeLoss	-648844	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	2778820	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	2118981	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	46207	usd
	AMMJ	Stock Based Compensation Third Party Shares StockBasedCompensationThirdPartyShares	65000	shares
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	117628	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1090628	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	1257188	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1090628	usd
	us-gaap	Net Income Loss NetIncomeLoss	-648844	usd
	us-gaap	Depreciation Depreciation	113362	usd
	us-gaap	Depreciation Depreciation	77810	usd
	AMMJ	Stockbased Compensation To Employees StockbasedCompensationToEmployees	65306	usd
	AMMJ	Stockbased Compensation To Employees StockbasedCompensationToEmployees	37008	usd
	AMMJ	Stockbased Compensation To Third Party StockbasedCompensationToThirdParty	29792	usd
	us-gaap	Property Plant And Equipment Disposals PropertyPlantAndEquipmentDisposals	324012	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	64930	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	55232	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	30187	usd
	AMMJ	Right To Use Lease Asset1 RightToUseLeaseAsset1	116191	usd
	AMMJ	Right To Use Lease Asset1 RightToUseLeaseAsset1	125889	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	211059	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	160608	usd
	AMMJ	Advances From Clients AdvancesFromClients	-1279080	usd
	AMMJ	Advances From Clients AdvancesFromClients	-197057	usd
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-11463	usd
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	46945	usd
	AMMJ	Increase Decrease In Litigation Settlement Liability IncreaseDecreaseInLitigationSettlementLiability	-150000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	116191	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	125889	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	68780	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-649784	usd
	us-gaap	Property Plant And Equipment Disposals PropertyPlantAndEquipmentDisposals	105011	usd
	us-gaap	Payments To Acquire Other Property Plant And Equipment PaymentsToAcquireOtherPropertyPlantAndEquipment	1100000	usd
	us-gaap	Increase Decrease In Intangible Assets Current IncreaseDecreaseInIntangibleAssetsCurrent	10305	usd
	us-gaap	Increase Decrease In Intangible Assets Current IncreaseDecreaseInIntangibleAssetsCurrent	5943	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-115316	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1429955	usd
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	117629	usd
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	1110477	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	130186	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	550000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-432371	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1240663	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-478907	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-839076	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	670423	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1723132	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	191516	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	884056	usd
	AMMJ	Stock Based Compensation Third Party StockBasedCompensationThirdParty	65000	usd
	AMMJ	Stock Issued For Receivables StockIssuedForReceivables	690000	usd
	AMMJ	Stock Issued For Acquisition StockIssuedForAcquisition	1100000	usd
CY2021Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2022Q3	AMMJ	Less Deposits Recognized As Revenue LessDepositsRecognizedAsRevenue	-4928797	usd
CY2021Q4	AMMJ	Less Deposits Recognized As Revenue LessDepositsRecognizedAsRevenue	-381094	usd
	AMMJ	Unaudited Interim Financial Statements UnauditedInterimFinancialStatements	<p id="xdx_846_ecustom--UnauditedInterimFinancialStatements_zo7JWrRvicS5" style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span id="xdx_865_z2uHuS93CgS7">Unaudited Interim Financial Statements</span></i></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. GAAP for interim financial information and with the instructions to Form 10-Q and Regulation S-X. Accordingly, the unaudited consolidated financial statements do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments consisting of normal recurring entries necessary for a fair statement of the periods presented for: (a) the financial position; (b) the result of operations; and (c) cash flows, have been made in order to make the financial statements presented not misleading. The results of operations for such interim periods are not necessarily indicative of operations for a full year.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84B_eus-gaap--UseOfEstimates_zRfPECoE7CEc" style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"><i><span id="xdx_86E_zaakdO3Qovy">Use of Estimates in Financial Reporting</span></i></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">The preparation of unaudited condensed consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the amount of assets and liabilities, and disclosures of contingent assets and liabilities, as of the date of the condensed consolidated financial statements during the periods presented. Actual results could differ from these estimates. Estimates and assumptions are reviewed periodically, and the effects of revisions are reflected in the consolidated financial statements in the period in which they are deemed to be necessary. Significant estimates made in the accompanying consolidated financial statements include but are not limited to following those related to revenue recognition, allowance for doubtful accounts and unbilled services, lives and recoverability of equipment and other long-lived assets, the allocation of the asset purchase price, contingencies, and litigation. The Company is subject to uncertainties, such as the impact of future events, economic, environmental, and political factors, and changes in the business climate; therefore, actual results may differ from those estimates. When no estimate in a given range is deemed to be better than any other when estimating contingent liabilities, the low end of the range is accrued. Accordingly, the accounting estimates used in the preparation of the Company’s consolidated financial statements will change as new events occur, as more experience is acquired, as additional information is obtained and as the Company’s operating environment changes. Changes in estimates are made when circumstances warrant. Such changes and refinements in estimation methodologies are reflected in reported results of operations; if material, the effects of changes in estimates are disclosed in the notes to the unaudited consolidated financial statements.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"> </p>
CY2022Q3	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2022Q3	us-gaap	Allowance For Doubtful Accounts Premiums And Other Receivables AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables	69415	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Premiums And Other Receivables AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables	69415	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	65310	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_84C_eus-gaap--ConcentrationRiskCreditRisk_zPFekXCSRvO3" style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"><i><span id="xdx_866_zfkKHPAZlul1">Significant Clients and Customers</span></i></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">During the nine months ended September 30, 2022, three customers accounted for <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20220930__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--RevenuesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--ThreeCustomerMember_z3S72JfcGnKb" title="Concentrations of credit risk">42.5</span>% of the Company’s total revenues for the period.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">During the nine months ended September 30, 2021, three customers accounted for <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20210930__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--RevenuesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--ThreeCustomerMember_zlqaNtYmIJm4" title="Concentrations of credit risk">42.5</span>% of the Company’s total revenues.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"/>
CY2021Q4	us-gaap	Goodwill Gross GoodwillGross	1985113	usd
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	70000	usd
	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	usd
CY2021	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	usd
	us-gaap	Advertising Expense AdvertisingExpense	98414	usd
	us-gaap	Advertising Expense AdvertisingExpense	33238	usd
CY2022Q3	AMMJ	Advance From Client AdvanceFromClient	1390972	usd
CY2021Q4	AMMJ	Advance From Client AdvanceFromClient	111892	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	431851	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	28690	usd
	AMMJ	Sales Return SalesReturn	0	usd
	AMMJ	Sales Return SalesReturn	0	usd
CY2022Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	542283	usd
	AMMJ	Related Party Transactions RelatedPartyTransactions	<p id="xdx_84A_ecustom--RelatedPartyTransactions_z1huh6XY7Dbc" style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"><i><span id="xdx_866_z8eKRSlQkeE9">Related Party Transactions</span></i></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">The Company follows FASB ASC subtopic 850-10, <i>Related Party Disclosures,</i> for the identification of related parties and disclosure of related party transactions.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">Pursuant to ASC 850-10-20, related parties include: a) affiliates of the Company; b) entities for which investments in their equity securities would be required, absent the election of the fair value option under the Fair Value Option Subsection of Section 825–10–15, to be accounted for by the equity method by the investing entity; c) trusts for the benefit of employees, such as pension and profit sharing trusts that are managed by or under the trusteeship of management; d) principal owners of the Company; e) management of the Company; f) other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests; and g) other parties that can significantly influence the management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"/>
CY2022Q3	AMMJ	Advance From Clients AdvanceFromClients	111892	usd
CY2021Q4	AMMJ	Advance From Clients AdvanceFromClients	88843	usd
CY2022Q3	AMMJ	Additional Deposits Received AdditionalDepositsReceived	6207877	usd
CY2021Q4	AMMJ	Additional Deposits Received AdditionalDepositsReceived	404143	usd
	AMMJ	Impact Of Covid19 Pandemic ImpactOfCovid19Pandemic	<p id="xdx_845_ecustom--ImpactOfCovid19Pandemic_zCmqHvmHAaXl" style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"><i><span id="xdx_86D_zJGO9BBL41p7">Impact of COVID-19 Pandemic</span></i></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">On March 11, 2020<i>, </i>the World Health Organization declared the current coronavirus (“COVID-<i>19”</i>) outbreak to be a global pandemic. In response to this declaration and the rapid spread of COVID-<i>19</i> within the United States, federal, state and local governments throughout the country have imposed varying degrees of restrictions on social and commercial activity to promote social distancing in an effort to slow the spread of the illness. These measures had a significant adverse impact upon many sectors of the economy, including retail commerce.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">In response to state and local measures and for protection of both employees, the Company made required changes to operations, which did not have a material impact upon operations or the financial condition of the Company.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">While the state and local governments have eased restrictions on restrictions and activities, it is possible that a resurgence in COVID-<i>19</i> cases could prompt a return to or new tighter restrictions to be instituted in the future. The Company is not aware of any specific event or circumstance that would require an update to its estimates or judgments or a revision of the carrying value of its assets or liabilities as of the date of issuance of these unaudited condensed consolidated financial statements.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"> </p>
CY2022Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	686242	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	808160	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	62223	usd
CY2022Q3	us-gaap	Accounts Receivable Gross AccountsReceivableGross	329341	usd
CY2021Q4	us-gaap	Accounts Receivable Gross AccountsReceivableGross	93856	usd
CY2022Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	69415	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	82540	usd
CY2022Q3	us-gaap	Accounts And Notes Receivable Net AccountsAndNotesReceivableNet	259926	usd
CY2021Q4	us-gaap	Accounts And Notes Receivable Net AccountsAndNotesReceivableNet	11316	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	745937	usd
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	70000	usd
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	0	usd
CY2022Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	68370	usd
CY2021Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	60900	usd
CY2022Q3	us-gaap	Inventory Work In Process InventoryWorkInProcess	239061	usd
CY2021Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	136266	usd
CY2022Q3	AMMJ	Finished Goods Soil FinishedGoodsSoil	42101	usd
CY2021Q4	AMMJ	Finished Goods Soil FinishedGoodsSoil	58594	usd
CY2022Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	2962	usd
CY2021Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	22848	usd
CY2022Q3	AMMJ	Total Inventory TotalInventory	352494	usd
CY2021Q4	AMMJ	Total Inventory TotalInventory	278608	usd
CY2022Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	99382	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	56019	usd
CY2022Q3	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	442901	usd
CY2021Q4	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	375832	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	818462	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	132221	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	46666	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	93333	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	93333	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	93333	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	53333	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	311113	usd
CY2022Q3	us-gaap	Intangible Assets Current IntangibleAssetsCurrent	691111	usd
CY2022Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	39106	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	74137	usd
CY2022Q3	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	14335	usd
CY2021Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	18428	usd
CY2022Q3	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	4959	usd
CY2021Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	592	usd
CY2022Q3	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	35685	usd
CY2021Q4	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	68561	usd
CY2022Q3	us-gaap	Accounts Payable And Other Accrued Liabilities AccountsPayableAndOtherAccruedLiabilities	94085	usd
CY2021Q4	us-gaap	Accounts Payable And Other Accrued Liabilities AccountsPayableAndOtherAccruedLiabilities	161718	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	40709	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	143429	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	184138	usd
CY2022Q3	AMMJ	Less Amount Representing Interest LessAmountRepresentingInterest	-57928	usd
CY2022Q3	AMMJ	Present Value Of Future Minimum Lease Payments PresentValueOfFutureMinimumLeasePayments	126210	usd
CY2022Q3	AMMJ	Less Current Obligations Under Leases LessCurrentObligationsUnderLeases	40709	usd
CY2022Q3	AMMJ	Longterm Lease Obligations LongtermLeaseObligations	85501	usd
CY2022Q3	us-gaap	Lessor Operating Lease Payments To Be Received Next Rolling Twelve Months LessorOperatingLeasePaymentsToBeReceivedNextRollingTwelveMonths	62384	usd
CY2022Q3	us-gaap	Lessor Operating Lease Payments To Be Received Rolling Year Two LessorOperatingLeasePaymentsToBeReceivedRollingYearTwo	77200	usd
CY2022Q3	us-gaap	Lessor Operating Lease Payments To Be Received Rolling Year Three LessorOperatingLeasePaymentsToBeReceivedRollingYearThree	49300	usd
CY2022Q3	us-gaap	Lessor Operating Lease Payments To Be Received Rolling Year Four LessorOperatingLeasePaymentsToBeReceivedRollingYearFour	51400	usd
CY2022Q3	us-gaap	Lessor Operating Lease Payments To Be Received Rolling Year Five LessorOperatingLeasePaymentsToBeReceivedRollingYearFive	53500	usd
CY2022Q3	us-gaap	Lessor Operating Lease Payments To Be Received After Rolling Year Five LessorOperatingLeasePaymentsToBeReceivedAfterRollingYearFive	36600	usd
CY2022Q3	us-gaap	Lessor Operating Lease Payments To Be Received LessorOperatingLeasePaymentsToBeReceived	330384	usd

Files In Submission

Name	View Source	Status
0001903596-22-000846-index-headers.html	Edgar Link	pending
0001903596-22-000846-index.html	Edgar Link	pending
0001903596-22-000846.txt	Edgar Link	pending
0001903596-22-000846-xbrl.zip	Edgar Link	pending
american_10q.htm	Edgar Link	pending
american_10qex31.htm	Edgar Link	pending
american_10qex32.htm	Edgar Link	pending
ammj-20220930.xsd	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_001.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
ammj-20220930_pre.xml	Edgar Link	unprocessable
ammj-20220930_def.xml	Edgar Link	unprocessable
ammj-20220930_cal.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
american_10q_htm.xml	Edgar Link	completed
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
ammj-20220930_lab.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AMMJ
American Cannabis Company, Inc. Stock $ammj

2022 Q4 Form 10-Q Financial Statement

#000190359622000846 Filed on November 21, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AMMJ American Cannabis Company, Inc. Stock $ammj

2022 Q4 Form 10-Q Financial Statement

#000190359622000846 Filed on November 21, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AMMJ
American Cannabis Company, Inc. Stock $ammj